P574: IBD patients should be stratified to guide out-of-hospital monitoring: ICHOM-derived outcomes from a dedicated IBD telephone clinic
ECCO '19 Copenhagen
2019
P575: Simple novel tacrolimus enemas are very effective in severe refractory proctitis
ECCO '19 Copenhagen
2019
P576: Therapeutic drug monitoring as predictive marker of mucosal healing in Crohn’s disease patients treated with anti-TNF: a prospective multi-centre study
ECCO '19 Copenhagen
2019
P577: Drug Induced Liver Injury (DILI) secondary to biologic therapy in IBD: ECCO- CONFER Series
ECCO '19 Copenhagen
2019
P578: Therapeutic strategies in the approach of paradoxical psoriasis in IBD: experience of a centre
ECCO '19 Copenhagen
2019
P579: Wearable Devices Can Predict Disease Activity in inflammatory bowel disease Patients
ECCO '19 Copenhagen
2019
P580: Improvement in disease activity is associated with less disability in a prospective study of paediatric transition patients with IBD
ECCO '19 Copenhagen
2019
P581: Complementary and alternative therapies for inflammatory bowel disease
ECCO '19 Copenhagen
2019
P582: Effectiveness and nephrotoxicity of long-term tacrolimus administration in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P583: Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on adalimumab
ECCO '19 Copenhagen
2019
P584: Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis
ECCO '19 Copenhagen
2019
P585: Efficacy of iDose dashboard forecast for individualising Infliximab therapy: an Indian experience
ECCO '19 Copenhagen
2019
P586: Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: a multi-centre retrospective cohort study
ECCO '19 Copenhagen
2019
P587: Quality of care indicators in inflammatory bowel disease: local pilot study
ECCO '19 Copenhagen
2019
P588: Tacrolimus suppositories: a safe and effective treatment for treatment-refractory proctitis
ECCO '19 Copenhagen
2019
P589: A population pharmacokinetic model to improve mucosal healing upon golimumab induction therapy in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P591: Low donor microbial engraftment after combined endoscopic and oral faecal microbiota transplant (FMT) in patients with antibiotic dependent pouchitis
ECCO '19 Copenhagen
2019
P592: Towards a Food Pharmacy: increased dietary quality reduces CRP and improves quality of life in IBD patients in remission
ECCO '19 Copenhagen
2019